Pain Control for Undergoing Costal Cartilage Harvesting
Status:
Not yet recruiting
Trial end date:
2024-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether injecting the U.S. Food and Drug
Administration (FDA) approved drug EXPAREL®, a long acting (approximately 96 hours) numbing
medication, will reduce pain after rib cartilage removal in comparison to the standard
injection of XYLOCAINE®.